AbbVie (ABBV)

AbbVie (ABBV) Income Statement


AbbVie Income Statement

Last quarter (Q1 2023), AbbVie's total revenue was $12.22B, a decrease of -9.70% from the same quarter last year. In Q1, AbbVie's net income was $239.00M. See AbbVie’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 56.74B$ 58.05B$ 56.20B$ 45.80B$ 33.27B$ 32.75B
Cost of Revenue
$ 17.35B$ 17.41B$ 17.45B$ 15.39B$ 7.44B$ 7.72B
Gross Profit
$ 39.39B$ 40.64B$ 38.75B$ 30.42B$ 25.83B$ 25.04B
Operating Expense
$ 22.92B$ 22.52B$ 19.86B$ 17.86B$ 12.84B$ 18.65B
Operating Income
$ 16.48B$ 18.12B$ 18.89B$ 12.56B$ 12.98B$ 6.38B
Net Non Operating Interest Income Expense
$ -1.96B$ -2.04B$ -2.38B$ -2.28B$ -1.51B$ -1.14B
Other Income Expense
$ 2.23B$ 2.45B$ -3.51B$ -6.88B$ -3.05B$ -42.00M
Pretax Income
$ 9.02B$ 13.48B$ 12.99B$ 3.40B$ 8.43B$ 5.20B
Tax Provision
$ 1.43B$ 1.63B$ 1.44B$ -1.22B$ 544.00M$ -490.00M
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
$ 7.56B$ 11.84B$ 11.47B$ 4.56B$ 7.84B$ 5.66B
Basic EPS
$ 2.18$ 6.65$ 0.41$ 2.73$ 5.30$ 3.67
Diluted EPS
$ 2.18$ 6.63$ 0.40$ 2.72$ 5.28$ 3.66
Basic Average Shares
$ 33.65B$ 1.77B$ 28.32B$ 1.67B$ 1.48B$ 1.54B
Diluted Average Shares
$ 33.75B$ 1.78B$ 28.43B$ 1.67B$ 1.48B$ 1.55B
Dividend Per Share
$ 2.82-$ 5.20$ 4.72$ 4.28$ 3.59
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
$ 3.60-$ 0.79$ 10.56$ 8.94$ 7.91
Rent Expense Supplemental
Total Expenses
$ 40.26B$ 39.94B$ 37.31B$ 33.24B$ 20.28B$ 26.37B
Net Income From Continuing And Discontinued Operation
$ 7.59B$ 11.85B$ 11.54B$ 4.62B$ 7.88B$ 5.69B
Normalized Income
$ 5.19B-$ 12.44B$ 5.54B$ 8.28B$ 5.70B
Interest Expense
$ 1.12B-$ 2.42B$ 2.45B$ 1.78B$ 1.35B
$ 11.07B$ 15.52B$ 15.41B$ 5.85B$ 10.21B$ 6.54B
$ 19.60B$ 24.00B$ 23.93B$ 12.32B$ 12.23B$ 8.31B
Currency in USD

AbbVie Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis